A recent report published by Infinium Global Research on
hydroxychloroquine market provides in-depth analysis of segments and
sub-segments in the global as well as regional hydroxychloroquine market. The
study also highlights the impact of drivers, restraints, and macro indicators
on the global and regional hydroxychloroquine market over the short term as
well as long term. The report is a comprehensive presentation of trends,
forecast and dollar values of global hydroxychloroquine market. According to
the report, the global hydroxychloroquine market is projected to grow at a
healthy CAGR over the forecast period of 2020-2026.
Hydroxychloroquine is an anti-malarial prescription drug
that has the capability to reduce fever and inflammation. The drug is mainly
sold under the brand name Plaquenil among others. It is also used in lupus and
arthritis patients as it helps in reducing pain, swelling and stiffness.
Moreover, as the drug also has the ability to regulate the activity of the
immune system, it is currently used in the treatment of COVID-19.
According to a number of studies, Hydroxychloroquine has
shown strong antiviral effects on the coronavirus infection. Early clinical
trial conducted in COVID-19 Chinese patients, showed that hydroxychloroquine had
a significant effect, both in terms of clinical outcome and viral clearance.
Moreover, it was one of the first potential agents to illustrate the ability to
slow the SARS-CoV-2, the novel coronavirus, in a laboratory. This has prompted
an increase in demand for the Hydroxychloroquine in the global markets for the
treatment of COVID-19. Furthermore, as the number of patients affected by the
COVID-19 pandemic is increasing globally, the demand for hydroxychloroquine is
also expected to increase exponentially. In addition, in certain developing
countries, malaria is on the rise, which will further increase the demand for
Hydroxychloroquine over the future years. However, the continuous intake of
Hydroxychloroquine causes side effects such as heart rhythm problems which is
likely to have a negative impact on the Hydroxychloroquine market. Nonetheless,
the ongoing clinical trials for the use of Hydroxychloroquine in infectious,
immune, neo-plastic, and neurological diseases will generate new opportunities
for the market growth.
Among the regions, North America will dominate the global
market over the forecast years owing to the rising use of the drug for COVID-19
treatment. The U.S. is the world’s most affected country by coronavirus
currently, by the number of cases, which has increased the demand for the drugs
in the North America region. In recent times, India, the major producer of Hydroxychloroquine
has exported 35.82 lakh tablets of the drug to the US along with nine metric
tons of active pharmaceutical ingredient or API required in the manufacturing
of the drug. However, Europe will hold the second-largest share as seven
European countries are among the ten most affected countries with coronavirus.
Furthermore, as more European countries are witnessing a surge in cases, the
usage of Hydroxychloroquine is expected to intensify in Europe over 2020.
Moreover, in the long term, the developing regions will emerge as the
predominant users of Hydroxychloroquine due to the increasing cases of malaria
in such countries
The report on global hydroxychloroquine market covers
segments such as route of administration, strength, and application. On the
basis of route of administration, the sub-markets include oral, and
intravenous. On the basis of strength, the sub-markets include 100 mg, 250 mg,
and 500 mg. On the basis of application, the sub-markets include rheumatoid
arthritis, malaria, covid-19, and others.
The report provides profiles of the companies in the market
such as Ipca Laboratories Ltd, Zydus Cadila, Novartis AG, Teva Pharmaceutical
Industries Ltd., Bayer AG, Rising Pharma Holdings Inc, Abcam plc, Mylan N.V.,
Abbott Laboratories, and Others.
The report provides deep insights into the demand forecasts,
market trends, and micro and macro indicators. In addition, this report
provides insights into the factors that are driving and restraining the growth
in this market. Moreover, The IGR-Growth Matrix analysis given in the report
brings an insight into the investment areas that existing or new market players
can consider. The report provides insights into the market using analytical tools
such as Porter's five forces analysis and DRO analysis of hydroxychloroquine
market. Moreover, the study highlights current market trends and provides
forecast from 2020-2026. We also have highlighted future trends in the market
that will affect the demand during the forecast period. Moreover, the
competitive analysis given in each regional market brings an insight into the
market share of the leading players.